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 A diagnostic decision support system (DDSS) is deﬁ ned 
as a methodology that provides guidance in situations 
involving complex decision sequences. DDSSs result in 
a systematic, ordered, and exhaustive evaluation of evi-
dence and weighting of individual items of evidence as 
they are combined to form the basis for a ﬁ nal decision. 
Most DDSSs provide a numeric measure of conﬁ dence in 
the ﬁ nal decision or diagnostic recommendation. Th e de-
cisive advantage of DDSSs is the ability to process descrip-
tive symbolic information, in contrast to systems limited 
to the handling of numerical information only for which 
extensive analytical procedures are already established. 
Most human knowledge and insight related to diagnostic 
and prognostic evaluation exist in symbolic form as con-
cepts and linguistic terms, so the DDSSs have facilitated 
systematic evaluation of evidence to provide diagnostic 
and prognostic decision support. 
 DDSSs may be implemented as inference networks (or 
Bayesian Belief Networks – BBNs), automated reasoning 
systems, case-based reasoning systems, or expert systems. 
In inference networks and automated reasoning systems, 
the emphasis is on uncertainty assessment of a given de-
cision sequence. In case-base reasoning, the emphasis is 
on prognostic assessment for an individual patient. In ex-
pert systems, the emphasis is on diagnostic or prognostic 
assessment, by making available a comprehensive knowl-
edge base of facts and professional experience. However, 
even though the emphasis is slightly diﬀ erent in these 
kinds of decision support systems, much of the method-
ology is shared. 
 A BBN consists of a decision node for the diagnostic 
alternatives and of evidence nodes for the diagnostic 
clues. Each clue is observed, rated, and assigned to a 
function with a given probability. Th e evidence is then 
forwarded to the decision node via a conditional prob-
ability link matrix. At the decision node, the belief in each 
diagnostic alternative is accumulated. A series of BBNs 
have already been successfully developed for prostate 
and non-prostate neoplasms (7-13) including comparing 
cancer with benign lesions and those with prostatic intra-
epithelial neoplasms. 
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